Ocular Therapeutix (OCUL) Presents at H.C. Wainwright Annual Global Investment Conference - Slideshow

(N A S DA Q : O C UL ) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM ANTONY MATTESSICH, CHIEF EXECUTIVE OFFICER MICHAEL GOLDSTEIN, MD, CHIEF MEDICAL OFFICER September 2020 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA®, ReSure® Sealant, or any of the Company's product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the ...